nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A2—nephron—nephrolithiasis	0.0432	0.181	CbGeAlD
Procainamide—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0423	0.0897	CbGpPWpGaD
Procainamide—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0401	0.163	CcSEcCtD
Procainamide—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0319	0.0676	CbGpPWpGaD
Procainamide—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0318	0.0674	CbGpPWpGaD
Procainamide—Probenecid—SLC2A9—nephrolithiasis	0.0232	0.541	CrCbGaD
Procainamide—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.022	0.0465	CbGpPWpGaD
Procainamide—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.02	0.0424	CbGpPWpGaD
Procainamide—Probenecid—SLC22A12—nephrolithiasis	0.0197	0.46	CrCbGaD
Procainamide—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0187	0.0395	CbGpPWpGaD
Procainamide—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.015	0.0609	CcSEcCtD
Procainamide—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0478	CcSEcCtD
Procainamide—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0466	CcSEcCtD
Procainamide—SCN9A—nephron tubule—nephrolithiasis	0.0114	0.0476	CbGeAlD
Procainamide—CYP2D6—urine—nephrolithiasis	0.011	0.0459	CbGeAlD
Procainamide—DNMT1—cortex of kidney—nephrolithiasis	0.00957	0.04	CbGeAlD
Procainamide—SLC22A2—nephron tubule—nephrolithiasis	0.00933	0.039	CbGeAlD
Procainamide—SCN4A—renal system—nephrolithiasis	0.00924	0.0386	CbGeAlD
Procainamide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00921	0.0375	CcSEcCtD
Procainamide—SCN4A—kidney—nephrolithiasis	0.00894	0.0373	CbGeAlD
Procainamide—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00878	0.0357	CcSEcCtD
Procainamide—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00874	0.0356	CcSEcCtD
Procainamide—SCN10A—nephron tubule—nephrolithiasis	0.00868	0.0362	CbGeAlD
Procainamide—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00856	0.0348	CcSEcCtD
Procainamide—SLC22A2—renal system—nephrolithiasis	0.00849	0.0354	CbGeAlD
Procainamide—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00848	0.018	CbGpPWpGaD
Procainamide—SLC22A2—kidney—nephrolithiasis	0.0082	0.0343	CbGeAlD
Procainamide—SLC22A2—cortex of kidney—nephrolithiasis	0.00799	0.0334	CbGeAlD
Procainamide—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00788	0.0167	CbGpPWpGaD
Procainamide—SCN2A—cortex of kidney—nephrolithiasis	0.0077	0.0322	CbGeAlD
Procainamide—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0076	0.0309	CcSEcCtD
Procainamide—SCN3A—renal system—nephrolithiasis	0.00719	0.03	CbGeAlD
Procainamide—SCN3A—kidney—nephrolithiasis	0.00695	0.029	CbGeAlD
Procainamide—SLC22A4—nephron tubule—nephrolithiasis	0.00692	0.0289	CbGeAlD
Procainamide—SCN3A—cortex of kidney—nephrolithiasis	0.00677	0.0283	CbGeAlD
Procainamide—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00672	0.0274	CcSEcCtD
Procainamide—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00639	0.0135	CbGpPWpGaD
Procainamide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00637	0.0135	CbGpPWpGaD
Procainamide—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0063	0.0256	CcSEcCtD
Procainamide—SLC22A4—renal system—nephrolithiasis	0.00629	0.0263	CbGeAlD
Procainamide—SLC22A4—kidney—nephrolithiasis	0.00609	0.0254	CbGeAlD
Procainamide—SLC22A1—renal system—nephrolithiasis	0.00599	0.025	CbGeAlD
Procainamide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00598	0.0243	CcSEcCtD
Procainamide—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00594	0.0126	CbGpPWpGaD
Procainamide—SLC22A4—cortex of kidney—nephrolithiasis	0.00593	0.0248	CbGeAlD
Procainamide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00592	0.0125	CbGpPWpGaD
Procainamide—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00586	0.0238	CcSEcCtD
Procainamide—SLC22A1—kidney—nephrolithiasis	0.00579	0.0242	CbGeAlD
Procainamide—SLC22A3—renal system—nephrolithiasis	0.00573	0.0239	CbGeAlD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00556	0.0118	CbGpPWpGaD
Procainamide—SLC22A3—kidney—nephrolithiasis	0.00554	0.0231	CbGeAlD
Procainamide—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00534	0.0217	CcSEcCtD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00508	0.0108	CbGpPWpGaD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00508	0.0108	CbGpPWpGaD
Procainamide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00491	0.02	CcSEcCtD
Procainamide—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00485	0.0103	CbGpPWpGaD
Procainamide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00465	0.0189	CcSEcCtD
Procainamide—SLC22A5—nephron tubule—nephrolithiasis	0.00458	0.0191	CbGeAlD
Procainamide—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00458	0.0186	CcSEcCtD
Procainamide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00452	0.0184	CcSEcCtD
Procainamide—BCHE—nephron tubule—nephrolithiasis	0.00446	0.0186	CbGeAlD
Procainamide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00426	0.0174	CcSEcCtD
Procainamide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00426	0.0174	CcSEcCtD
Procainamide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00421	0.0172	CcSEcCtD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00419	0.00888	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00418	0.00885	CbGpPWpGaD
Procainamide—SLC22A5—renal system—nephrolithiasis	0.00417	0.0174	CbGeAlD
Procainamide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00412	0.0168	CcSEcCtD
Procainamide—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00408	0.00864	CbGpPWpGaD
Procainamide—SLC22A5—kidney—nephrolithiasis	0.00403	0.0168	CbGeAlD
Procainamide—Shock—Hydrochlorothiazide—nephrolithiasis	0.00402	0.0164	CcSEcCtD
Procainamide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00401	0.00849	CbGpPWpGaD
Procainamide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.004	0.0163	CcSEcCtD
Procainamide—SLC22A5—cortex of kidney—nephrolithiasis	0.00392	0.0164	CbGeAlD
Procainamide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0039	0.0159	CcSEcCtD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00385	0.00816	CbGpPWpGaD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00385	0.00816	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00383	0.00812	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00383	0.00812	CbGpPWpGaD
Procainamide—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00382	0.0155	CcSEcCtD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00382	0.00809	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00382	0.00809	CbGpPWpGaD
Procainamide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00374	0.00792	CbGpPWpGaD
Procainamide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00373	0.0079	CbGpPWpGaD
Procainamide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00372	0.0152	CcSEcCtD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00358	0.00759	CbGpPWpGaD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00358	0.00759	CbGpPWpGaD
Procainamide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00355	0.0145	CcSEcCtD
Procainamide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00347	0.00736	CbGpPWpGaD
Procainamide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00337	0.0137	CcSEcCtD
Procainamide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00334	0.0136	CcSEcCtD
Procainamide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00325	0.0132	CcSEcCtD
Procainamide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00323	0.0132	CcSEcCtD
Procainamide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00323	0.0132	CcSEcCtD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00319	0.00676	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00317	0.00671	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00317	0.00671	CbGpPWpGaD
Procainamide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00301	0.0123	CcSEcCtD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00297	0.0063	CbGpPWpGaD
Procainamide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00293	0.0119	CcSEcCtD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0029	0.00615	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0029	0.00615	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0029	0.00613	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0029	0.00613	CbGpPWpGaD
Procainamide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00289	0.0118	CcSEcCtD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00282	0.00598	CbGpPWpGaD
Procainamide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0028	0.0114	CcSEcCtD
Procainamide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0027	0.011	CcSEcCtD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0027	0.00572	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0027	0.00572	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00269	0.0057	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00269	0.0057	CbGpPWpGaD
Procainamide—CYP2D6—renal system—nephrolithiasis	0.00269	0.0112	CbGeAlD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00263	0.00557	CbGpPWpGaD
Procainamide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0026	0.0106	CcSEcCtD
Procainamide—CYP2D6—kidney—nephrolithiasis	0.0026	0.0109	CbGeAlD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00258	0.00547	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00258	0.00547	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00245	0.00519	CbGpPWpGaD
Procainamide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00988	CcSEcCtD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00241	0.0051	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0024	0.00509	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0024	0.00509	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0024	0.00508	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00239	0.00506	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00239	0.00506	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00238	0.00505	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00238	0.00505	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00224	0.00475	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00224	0.00475	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.00216	0.00457	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00213	0.00451	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00212	0.0045	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00207	0.00438	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00196	0.00415	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00196	0.00415	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00195	0.00413	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00195	0.00413	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00194	0.00411	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00194	0.00411	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00182	0.00386	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00182	0.00386	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00182	0.00386	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00182	0.00386	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0017	0.0036	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0017	0.0036	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00169	0.00359	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00169	0.00359	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00162	0.00344	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00162	0.00344	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00158	0.00334	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00158	0.00334	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00151	0.0032	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0015	0.00317	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0015	0.00317	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00148	0.00313	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00148	0.00313	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00147	0.00312	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00147	0.00312	CbGpPWpGaD
Procainamide—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00145	0.00308	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00145	0.00308	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00141	0.00298	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0014	0.00296	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0014	0.00296	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00137	0.00291	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00137	0.00291	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00137	0.0029	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00137	0.0029	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00134	0.00283	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0013	0.00275	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00124	0.00264	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00122	0.00259	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00122	0.00259	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00122	0.00259	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00122	0.00259	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00122	0.00258	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00122	0.00258	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00121	0.00257	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00114	0.00241	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00114	0.00241	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000978	0.00207	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000975	0.00206	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000936	0.00198	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000926	0.00196	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000926	0.00196	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000863	0.00183	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000863	0.00183	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000861	0.00182	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000861	0.00182	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GRHPR—nephrolithiasis	0.000848	0.0018	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000802	0.0017	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000802	0.0017	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000802	0.0017	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000767	0.00163	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000767	0.00163	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AGXT—nephrolithiasis	0.000756	0.0016	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000715	0.00151	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000715	0.00151	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000707	0.0015	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GRHPR—nephrolithiasis	0.000668	0.00141	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—SLC26A1—nephrolithiasis	0.000643	0.00136	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APRT—nephrolithiasis	0.000643	0.00136	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000642	0.00136	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000613	0.0013	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000611	0.00129	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GRHPR—nephrolithiasis	0.000596	0.00126	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AGXT—nephrolithiasis	0.000595	0.00126	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000572	0.00121	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000559	0.00118	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GRHPR—nephrolithiasis	0.000532	0.00113	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AGXT—nephrolithiasis	0.000531	0.00112	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SLC26A1—nephrolithiasis	0.000506	0.00107	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APRT—nephrolithiasis	0.000506	0.00107	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.000496	0.00105	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000478	0.00101	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AGXT—nephrolithiasis	0.000474	0.001	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AQP1—nephrolithiasis	0.000458	0.00097	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APRT—nephrolithiasis	0.000451	0.000956	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC26A1—nephrolithiasis	0.000451	0.000956	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.000446	0.000945	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.000442	0.000936	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.000434	0.000919	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CHRM3—nephrolithiasis	0.000414	0.000877	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	0.000403	0.000854	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APRT—nephrolithiasis	0.000403	0.000854	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	0.000379	0.000803	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.000376	0.000796	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APRT—nephrolithiasis	0.000376	0.000796	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AQP1—nephrolithiasis	0.000361	0.000764	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000345	0.000731	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CHRM3—nephrolithiasis	0.000326	0.000691	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AQP1—nephrolithiasis	0.000322	0.000681	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	0.000316	0.000669	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000314	0.000664	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CHRM3—nephrolithiasis	0.000291	0.000616	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AQP1—nephrolithiasis	0.000287	0.000609	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	0.000287	0.000607	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000274	0.00058	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.000268	0.000567	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CHRM3—nephrolithiasis	0.00026	0.00055	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	0.000256	0.000543	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000256	0.000543	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000244	0.000517	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000242	0.000513	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000208	0.00044	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000208	0.00044	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	0.000185	0.000392	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTH—nephrolithiasis	0.000169	0.000359	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000148	0.000313	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000134	0.000283	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	8.5e-05	0.00018	CbGpPWpGaD
